Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 4, 2011, Pages 484-489

  Knapik, Piotr ^a   Cieśla, Daniel ^a   Filipiak, Krzysztof ^a   Knapik, Małgorzata ^a   Zembala, Marian ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Coronary surgery; Diabetes mellitus; Glycosylated hemoglobin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; NITRATE; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ARTERY GRAFT; ARTICLE; ASSISTED VENTILATION; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY SURGERY; CORONARY STENT; DIABETES MELLITUS; DIABETIC PATIENT; DIET THERAPY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN TREATMENT; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; STROKE; SURGICAL MORTALITY; SURGICAL PATIENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; WOUND INFECTION;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79952536601     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.07.037     Document Type: Article

References (25)

1. Engoren M., Habib R.H., Zacharias A., Schwann T.A., Riordan C.J., Durham S.J., Shah A. The prevalence of elevated hemoglobin A1c in patients undergoing coronary artery bypass surgery. J Cardiothorac Surg 2008, 3:63.
2. Matsuura K., Imamaki M., Ishida A., Shimura H., Niitsuma Y., Miyazaki M. Off-pump coronary artery bypass grafting for poorly controlled diabetic patients. Ann Thorac Cardiovasc Surg 2009, 15:18-22.
3. Alserius T., Anderson R.E., Hammar N., Nordqvist T., Ivert T. Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery. Scand Cardiovasc J 2008, 42:392-398.
4. Halkos M.E., Puskas J.D., Lattouf O.M., Kilgo P., Kerendi F., Song H.K., Guyton R.A., Thourani V.H. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2008, 136:631-640.
5. Halkos M.E., Lattouf O.M., Puskas J.D., Kilgo P., Cooper W.A., Morris C.D., Guyton R.A., Thourani V.H. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg 2008, 86:1431-1437.
6. Roques F., Michel P., Goldstone A.R., Nashef S.A. The logistic EuroSCORE. Eur Heart J 2003, 24:882-883.
7. Carrier M., Pellerin M., Perrault L.P., Solymoss B.C., Pelletier L.C. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg 2000, 69:435-440.
8. Calandra T., Cohen J., International Sepsis Forum Definition of Infection in the ICU Consensus Conference The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005, 33:1538-1548.
9. Furnary A.P., Gao G., Grunkemeier G.L., Wu Y., Zerr K.J., Bookin S.O., Floten H.S., Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003, 125:1007-1021.
10. Estrada C.A., Young J.A., Nifong L.W., Chitwood W.R. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003, 75:1392-1399.
11. Alserius T., Hammar N., Nordqvist T., Ivert T. Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2009, 138:1115-1122.
12. Hadjinikolaou L., Klimatsidas M., Maria Iacona G., Spyt T., Samani N.J. Short- and medium-term survival following coronary artery bypass surgery in British Indo-Asian and white Caucasian individuals: impact of diabetes mellitus. Interact Cardiovasc Thorac Surg 2010, 10:389-393.
13. Malmberg K., Ryden L., Wedel H., Birkeland K., Bootsma A., Dickstein K., Efendic S., Fisher M., Hamsten A., Herlitz J., Hildebrandt P., MacLeod K., Laakso M., Torp-Pedersen C., Waldenström A. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005, 26:650-661. DIGAMI 2 Investigators.
14. Woods S.E., Smith J.M., Sohail S., Sarah A., Engle A. The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery: an 8-year prospective cohort study. Chest 2004, 126:1789-1795.
15. Carson J.L., Scholz P.M., Chen A.Y., Peterson E.D., Gold J., Schneider S.H. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002, 40:418-423.
16. Filsoufi F., Rahmanian P.B., Castillo J.G., Mechanick J.I., Sharma S.K., Adams D.H. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2007, 6:753-758.
17. Au W.K., Lam K.T., Cheng L.C., Chiu S.W. Impact of diabetes on early and mid-term survival after coronary artery bypass graft surgery in the Hong Kong Chinese population. Hong Kong Med J 2009, 15:173-178.
18. Marcheix B., Vanden Eynden F., Demers P., Bouchard D., Cartier R. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery. Ann Thorac Surg 2008, 86:1181-1188.
19. Czech B., Kucewicz-Czech E., Pacholewicz J., Wojarski J., Puzio J., Przybylski R., Farmas A., Ryfiński B., Zembala M. Early results of coronary artery bypass graft surgery in women. Kardiol Pol 2007, 65:627-633.
20. Knapik P., Nadziakiewicz P., Urbanska E., Saucha W., Herdynska M., Zembala M. Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery. Ann Thorac Surg 2009, 87:1859-1865.
21. Lauruschkat A.H., Arnrich B., Albert A.A., Walter J.A., Amann B., Rosendahl U.P., Alexander T., Ennker J. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation 2005, 112:2397-2402.
22. Thielmann M., Neuhäuser M., Knipp S., Kottenberg-Assenmacher E., Marr A., Pizanis N., Hartmann M., Kamler M., Massoudy P., Jakob H. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007, 134:470-476.
23. Polish National Registry of Cardiac Surgical Procedures, Warsaw 2008. Polish National Registry of Cardiac Surgical Procedures, Warsaw; 2008.
24. Sayed S., Fischer S., Karck M., Hassouna A., Haverich A. Effect of different preoperative patient characteristics on coronary surgery outcome: a comparative study between a developing and a developed country. J Card Surg 2009, 24:275-280.
25. Knapik P., Rozentryt P., Nadziakiewicz P., Polonski L., Zembala M. Retrospective cross-validation of simplified predictive index for renal replacement therapy after cardiac surgery. Interact Cardiovasc Thorac Surg 2008, 7:1101-1106.